The company was founded in December 1999 and is a company listed on the small and medium board of the Shenzhen Stock Exchange. After years of development, industrial restructuring and business integration, the company has formed an operating model of Nengte Technology Co., Ltd. and Shanghai Sumi Information Technology Co., Ltd., which is committed to becoming a leading global enterprise in the R&D and production of pharmaceutical raw materials, animal nutrition, and new material products, and Shanghai Sumi Information Technology Co., Ltd., an e-commerce platform enterprise for the plasticization industry, as two core subsidiaries, and investment real estate leasing in science and technology venture industrial parks. The company's main business is pharmaceutical intermediates R&D, production and sales business and investment in vitamin E R&D, production and sales business; plastic trade e-commerce business; investment real estate leasing business; and gold mining business. The company's main products include montelukast sodium intermediates and rosofastatin intermediates. Corporate honors include Top 100 Supply Chain E-Commerce Cases, China's Top 100 Commodity E-Commerce Companies in 2018, governing units of the Shanghai Pudong E-Commerce Industry Association, and 2017 China's Top 100 B2B Companies.
No Data